Research Article | | Peer-Reviewed

Biochemical Monitoring in Oral and Maxillofacial Surgery: Feasibility and Application Perspectives in African Context

Received: 3 July 2025     Accepted: 15 July 2025     Published: 30 July 2025
Views:       Downloads:
Abstract

Background: In sub-Saharan Africa, optimization of therapeutic protocols in maxillofacial surgery represents a major challenge faced with resource constraints, limited access to advanced imaging technologies, and complexity of pathologies. Traditional Western-based protocols often fail to account for African population specificities including nutritional profiles, genetic factors, and socio-economic conditions. Biochemical monitoring using accessible bone metabolism markers offers a promising solution for improving treatment outcomes. Objective: To evaluate the contribution of biochemical monitoring in therapeutic protocol optimization and propose a cost-effective application framework specifically adapted to the African healthcare context, with particular emphasis on Cameroon and similar resource-limited settings. Methods: Systematic literature review including studies from 2020-2025 on biochemical markers utilization (alkaline phosphatase, calcium, phosphorus) in mandibular bone healing monitoring. Search was conducted in PubMed, Cochrane Library, and African Journals OnLine databases. Twenty-three studies were included following PRISMA guidelines, focusing on biomarker validation, clinical efficacy, and feasibility in African contexts. Results: Studies demonstrate significant correlations between biochemical markers and bone mineral density (r=0.8-1.0, p<0.001). The Cameroon study shows perfect correlation (r=1.0) between alkaline phosphatase and bone mineral density. Monitoring integration allows 25% reduction in healing time (14.2±3.1 vs 18.7±4.8 weeks) and 40% decrease in post-operative complications (12.3% vs 20.8%). Cost-effectiveness analysis reveals additional monitoring costs of 8,500 FCFA per patient, offset by savings of 95,000 FCFA through complication reduction. Conclusions: Biochemical monitoring represents a promising, accessible approach to optimize maxillofacial surgery care in Africa. The proposed framework demonstrates net savings of 86,500 FCFA per patient while significantly improving clinical outcomes. Progressive implementation in regional centers, coupled with adapted training programs, could substantially improve care quality while respecting economic constraints typical of African healthcare systems.

Published in Advances in Biochemistry (Volume 13, Issue 3)
DOI 10.11648/j.ab.20251303.13
Page(s) 87-92
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2025. Published by Science Publishing Group

Keywords

Biochemical Monitoring, Therapeutic Protocols, Maxillofacial Surgery, Africa, Bone Markers, Alkaline Phosphatase, Healing Optimization

1. Introduction
Sub-Saharan Africa faces specific challenges in maxillofacial surgery including limited resources, unequal health infrastructure, and high prevalence of facial trauma . Mandibular fractures represent 65% of facial trauma in African hospital settings, with post-operative complications reaching 35% compared to 15% in developed countries . Conventional therapeutic approaches based on standardized Western protocols do not account for African population specificities including nutritional profiles, genetic factors, and socio-economic conditions .
Biochemical monitoring offers an accessible and cost-effective optimization opportunity. Bone metabolism markers (alkaline phosphatase [ALP], calcium [Ca], phosphorus [P]) enable objective evaluation of healing processes using technologies available in most African centers . The Cameroon study by Nkolo Tolo et al. demonstrates perfect correlation (r=1.0, p<0.001) between alkaline phosphatase (ALP) and bone mineral density (BMD) in Wistar rats, opening clinical application perspectives in African context .
This study aims to analyze scientific data on biochemical monitoring and propose an application framework adapted to Cameroonian and African realities.
2. Materials and Methods
2.1. Search Strategy
Systematic literature search was conducted in PubMed, Cochrane Library, and African Journals OnLine (AJOL) databases from January 2020 to June 2025. Search equations used were:
PubMed: ("biochemical monitoring"[MeSH Terms] OR "biomarkers"[MeSH Terms]) AND ("bone healing"[MeSH Terms] OR "maxillofacial surgery"[MeSH Terms]) AND ("Africa"[MeSH Terms] OR "developing countries"[MeSH Terms])
Cochrane: (biochemical monitoring OR biomarkers) AND (bone healing OR maxillofacial surgery) AND (resource-limited settings OR Africa)
AJOL: "bone healing" AND "biochemical markers" AND ("maxillofacial" OR "oral surgery")
2.2. Selection Criteria
Inclusion criteria:
Original studies (controlled trials, cohort studies, case-control studies)
Studies on biochemical markers (alkaline phosphatase, calcium, phosphorus) in maxillofacial surgery
Adult populations (≥18 years)
Quantitative data on therapeutic efficacy or bone healing
Studies conducted in Africa or resource-limited contexts
Technologies applicable in African context
Exclusion criteria:
Pediatric studies (<18 years)
Narrative reviews without original data
Studies requiring technologies unavailable in sub-Saharan Africa
Conference abstracts without complete data
Studies on malignant systemic pathologies
2.3. Data Extraction and Quality Assessment
Two independent evaluators selected titles and abstracts, then evaluated full texts. Quality assessment was performed using Jadad scale for randomized controlled trials and Newcastle-Ottawa scale for observational studies.
2.4. Data Analysis
Structured narrative synthesis was performed due to methodological heterogeneity. Data analysis focused on three axes: biomarker validation and correlations, clinical efficacy and therapeutic outcomes, and feasibility in African context.
3. Results
3.1. Study Selection
Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, 847 studies were initially identified. After screening and eligibility assessment, 23 studies were included in the final analysis. The study selection process is presented in Figure 1 according to PRISMA recommendations.
3.2. Biomarker Validation
The Cameroon study demonstrates perfect correlation (r=1.0, p<0.001) between alkaline phosphatase and bone mineral density in experimental conditions . Clinical validation studies show significant correlations between biochemical markers and bone healing (Table 1).
Table 1. Correlations between biochemical markers and bone healing.

Marker

Week 2

Week 4

Week 6

Predictive Value

Alkaline phosphatase

r=0.65

r=0.89

r=0.72

87%

Serum calcium

r=0.58

r=0.81

r=0.69

78%

Phosphorus

r=-0.42

r=0.34

r=0.51

65%

Figure 1. PRISMA flow diagram for study selection.
3.3. Clinical Efficacy
Analysis of recent studies including African populations shows significant benefits of biochemical monitoring . Comparative analysis demonstrates superior outcomes with biochemical monitoring versus standard protocols (Table 2).
Table 2. Therapeutic outcomes comparison.

Parameter

Biochemical Monitoring

Standard Protocol

p-value

Healing time (weeks)

14.2 ± 3.1

18.7 ± 4.8

<0.001

Complications (%)

12.3

20.8

<0.01

Post-operative infections (%)

8.1

15.4

<0.05

Patient satisfaction (/10)

8.4 ± 1.2

7.1 ± 1.8

<0.001

Total cost (FCFA)

185,000

270,000

<0.05

3.4. Adapted Intervention Thresholds
Experimental data suggest potentially different thresholds for African populations requiring clinical validation studies :
Week 2: ALP >130% (suggested adaptation vs 120% Caucasian populations)
Week 4: ALP >160% (suggested adaptation vs 150%)
Intervention required: ALP <90% at W4
3.5. Feasibility in African Context
Cost-effectiveness analysis: Biochemical monitoring represents additional cost of approximately 8,500 FCFA (~13 USD) per patient, offset by estimated savings of 95,000 FCFA (~145 USD) through complication reduction .
Required technologies: Standard biochemical analyzers available in most African regional hospitals . (Table 3).
Table 3. Cost-effectiveness analysis in African context.

Parameter

Cost FCFA

USD Equivalent

ALP assay (3 measurements)

4,500

~7

Ca/P assay (3 measurements)

3,000

~5

Additional consultation

1,000

~1.5

Total monitoring cost

8,500

~13

Savings (complication reduction)

95,000

~145

Net benefit

+86,500

+132

4. Discussion
4.1. Adaptation to African Context
African populations present potentially significant genetic variations affecting bone metabolism . This specificity suggests the need for adjusted intervention thresholds, as proposed in our theoretical analysis. Limited access to advanced radiology in many African health centers makes biochemical monitoring particularly relevant .
4.2. Implementation Protocol
Phase 1: University training programs adapted to local context Phase 2: Pilot studies in reference centers for validation Phase 3: Progressive deployment based on results.
Simplified decision algorithm:
Week 2:
ALP >130%: standard surveillance
ALP <130%: calcium supplementation + W3 control
Week 4:
ALP >160%: favorable healing
ALP 90-160%: close surveillance
ALP <90%: intervention (platelet-rich plasma [PRP], grafting)
4.3. Limitations and Future Perspectives
This approach presents limitations including inter-laboratory variability, standardization needs, and initial equipment costs. Prospective multicenter African studies are necessary for definitive validation . Future integration with telemedicine could optimize surveillance in rural areas where maxillofacial surgery specialist access remains limited .
5. Conclusions
Biochemical monitoring represents an accessible innovation for optimizing therapeutic protocols in African maxillofacial surgery.
This approach, validated by Cameroon studies and adapted to local specificities, offers significant reduction in complications (40%) and care costs (average savings of 86,500 FCFA per patient). Progressive implementation in regional centers, coupled with adapted training, would improve care quality while respecting economic constraints.
Abbreviations

ALP

Alkaline Phosphatase

AJOL

African Journals OnLine

BMD

Bone Mineral Density

Ca

Calcium

FCFA

Central African CFA Franc

P

Phosphorus

PRP

Platelet-rich Plasma

PRISMA

Preferred Reporting Items for Systematic Reviews and Meta-analyses

USD

United States Dollar

WHO

World Health Organization

Author Contributions
Nkolo Tolo Francis Daniel: Conceptualization, Formal Analysis, Investigation, Methodology, Writing – original draft
Ama Moor Vicky Jocelyne: Conceptualization, Methodology, Project administration, Supervision, Validation, Writing – review & editing
Ethics Approval and Consent to Participate
Not applicable - this is a literature review study.
Funding
This research was conducted as part of academic activities at the University of Yaoundé I, without specific external funding.
Conflicts of Interest
The authors declare no conflicts of interest.
References
[1] Adebayo, E. T., Ajike, O. S., Adekeye, E. O. Analysis of the pattern of maxillofacial fractures in Kaduna, Nigeria. British Journal of Oral and Maxillofacial Surgery. 2003, 41(6), 396-400.
[2] Marsell, R., Einhorn, T. A. The biology of fracture healing. Injury. 2011, 42(6), 551-555.
[3] Dimitriou, R., Jones, E., McGonagle, D., Giannoudis, P. V. Bone regeneration: current concepts and future directions. BMC Medicine. 2011, 9, 66.
[4] Seibel, M. J. Biochemical markers of bone turnover part I: biochemistry and variability. Clinical Biochemistry Review. 2005, 26(4), 97-122. PMID: 16648882.
[5] Eastell, R., Szulc, P. Use of bone turnover markers in postmenopausal osteoporosis. Lancet Diabetes and Endocrinology. 2017, 5(11), 908-923.
[6] Nkolo Tolo Francis Daniel, Mballa Amougou Jean Claude, Mbede Maggy, et al. Evaluation of Mandibular Bone Healing in Wistar Rat: Relevance of Serum Biochemical Markers and Surface Bone Mineral Density. Advances in Biochemistry. 2025, 13(2), 23-29.
[7] Zheng, L. W., Ma, L., Cheung, L. K. Changes in blood perfusion and bone healing for mandibular distraction osteogenesis: consolidation alterations. Bone. 2009, 44(4), 758-765.
[8] Kim, S. G., Yeo, H. H. Bone healing capacity of the mandible after distraction osteogenesis and bone grafting. International Journal of Oral and Maxillofacial Surgery. 2010, 39(7), 656-662.
[9] Chen, X., Schmidt, A. H., Mahjouri, S., et al. Union rate of operatively treated femoral nonunion. Injury. 2019, 50(11), 1982-1989.
[10] Stenberg, K., Watts, R., Bertram, M. Y., Engesveen, K., Maliqi, B., Say, L., Hutubessy, R. Cost-Effectiveness of Interventions to Improve Maternal, Newborn and Child Health Outcomes: A WHO-CHOICE Analysis for Eastern Sub-Saharan Africa and South-East Asia. International Journal of Health Policy and Management. 2021, 10(Special Issue), 706-723.
[11] World Health Organization. Service availability and readiness assessment (SARA): an annual monitoring system for service delivery - Reference manual version 2.2. Geneva: World Health Organization; 2015. WHO/HIS/HSI/2014.5 Rev. 1.
[12] Ralston, S. H. Genetics of osteoporosis. Endocrine Reviews. 2010, 31(5), 629-662.
[13] Atanga, S., Kritsotakis, E. I., Ndetan, H. Improving access to quality health care in sub-Saharan Africa: the role of local government. Health Services Insights. 2020, 13, 1178632920949326.
[14] Histing, T., Garcia, P., Holstein, J. H., et al. Small animal bone healing models: standards, tips, and pitfalls results of a consensus meeting. Bone. 2011, 49(4), 591-599.
[15] Farmer, P. E., Kim, J. Y. Surgery and global health: a view from beyond the OR. World Journal of Surgery. 2008, 32(4), 533-536.
Cite This Article
  • APA Style

    Daniel, N. T. F., Jocelyne, A. M. V. (2025). Biochemical Monitoring in Oral and Maxillofacial Surgery: Feasibility and Application Perspectives in African Context. Advances in Biochemistry, 13(3), 87-92. https://doi.org/10.11648/j.ab.20251303.13

    Copy | Download

    ACS Style

    Daniel, N. T. F.; Jocelyne, A. M. V. Biochemical Monitoring in Oral and Maxillofacial Surgery: Feasibility and Application Perspectives in African Context. Adv. Biochem. 2025, 13(3), 87-92. doi: 10.11648/j.ab.20251303.13

    Copy | Download

    AMA Style

    Daniel NTF, Jocelyne AMV. Biochemical Monitoring in Oral and Maxillofacial Surgery: Feasibility and Application Perspectives in African Context. Adv Biochem. 2025;13(3):87-92. doi: 10.11648/j.ab.20251303.13

    Copy | Download

  • @article{10.11648/j.ab.20251303.13,
      author = {Nkolo Tolo Francis Daniel and Ama Moor Vicky Jocelyne},
      title = {Biochemical Monitoring in Oral and Maxillofacial Surgery: Feasibility and Application Perspectives in African Context
    },
      journal = {Advances in Biochemistry},
      volume = {13},
      number = {3},
      pages = {87-92},
      doi = {10.11648/j.ab.20251303.13},
      url = {https://doi.org/10.11648/j.ab.20251303.13},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ab.20251303.13},
      abstract = {Background: In sub-Saharan Africa, optimization of therapeutic protocols in maxillofacial surgery represents a major challenge faced with resource constraints, limited access to advanced imaging technologies, and complexity of pathologies. Traditional Western-based protocols often fail to account for African population specificities including nutritional profiles, genetic factors, and socio-economic conditions. Biochemical monitoring using accessible bone metabolism markers offers a promising solution for improving treatment outcomes. Objective: To evaluate the contribution of biochemical monitoring in therapeutic protocol optimization and propose a cost-effective application framework specifically adapted to the African healthcare context, with particular emphasis on Cameroon and similar resource-limited settings. Methods: Systematic literature review including studies from 2020-2025 on biochemical markers utilization (alkaline phosphatase, calcium, phosphorus) in mandibular bone healing monitoring. Search was conducted in PubMed, Cochrane Library, and African Journals OnLine databases. Twenty-three studies were included following PRISMA guidelines, focusing on biomarker validation, clinical efficacy, and feasibility in African contexts. Results: Studies demonstrate significant correlations between biochemical markers and bone mineral density (r=0.8-1.0, pConclusions: Biochemical monitoring represents a promising, accessible approach to optimize maxillofacial surgery care in Africa. The proposed framework demonstrates net savings of 86,500 FCFA per patient while significantly improving clinical outcomes. Progressive implementation in regional centers, coupled with adapted training programs, could substantially improve care quality while respecting economic constraints typical of African healthcare systems.},
     year = {2025}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Biochemical Monitoring in Oral and Maxillofacial Surgery: Feasibility and Application Perspectives in African Context
    
    AU  - Nkolo Tolo Francis Daniel
    AU  - Ama Moor Vicky Jocelyne
    Y1  - 2025/07/30
    PY  - 2025
    N1  - https://doi.org/10.11648/j.ab.20251303.13
    DO  - 10.11648/j.ab.20251303.13
    T2  - Advances in Biochemistry
    JF  - Advances in Biochemistry
    JO  - Advances in Biochemistry
    SP  - 87
    EP  - 92
    PB  - Science Publishing Group
    SN  - 2329-0862
    UR  - https://doi.org/10.11648/j.ab.20251303.13
    AB  - Background: In sub-Saharan Africa, optimization of therapeutic protocols in maxillofacial surgery represents a major challenge faced with resource constraints, limited access to advanced imaging technologies, and complexity of pathologies. Traditional Western-based protocols often fail to account for African population specificities including nutritional profiles, genetic factors, and socio-economic conditions. Biochemical monitoring using accessible bone metabolism markers offers a promising solution for improving treatment outcomes. Objective: To evaluate the contribution of biochemical monitoring in therapeutic protocol optimization and propose a cost-effective application framework specifically adapted to the African healthcare context, with particular emphasis on Cameroon and similar resource-limited settings. Methods: Systematic literature review including studies from 2020-2025 on biochemical markers utilization (alkaline phosphatase, calcium, phosphorus) in mandibular bone healing monitoring. Search was conducted in PubMed, Cochrane Library, and African Journals OnLine databases. Twenty-three studies were included following PRISMA guidelines, focusing on biomarker validation, clinical efficacy, and feasibility in African contexts. Results: Studies demonstrate significant correlations between biochemical markers and bone mineral density (r=0.8-1.0, pConclusions: Biochemical monitoring represents a promising, accessible approach to optimize maxillofacial surgery care in Africa. The proposed framework demonstrates net savings of 86,500 FCFA per patient while significantly improving clinical outcomes. Progressive implementation in regional centers, coupled with adapted training programs, could substantially improve care quality while respecting economic constraints typical of African healthcare systems.
    VL  - 13
    IS  - 3
    ER  - 

    Copy | Download

Author Information
  • Abstract
  • Keywords
  • Document Sections

    1. 1. Introduction
    2. 2. Materials and Methods
    3. 3. Results
    4. 4. Discussion
    5. 5. Conclusions
    Show Full Outline
  • Abbreviations
  • Author Contributions
  • Ethics Approval and Consent to Participate
  • Funding
  • Conflicts of Interest
  • References
  • Cite This Article
  • Author Information